PRMT3-mediated arginine methylation of IGF2BP1 promotes oxaliplatin resistance in liver cancer.
Shi Y, Niu Y, Yuan Y, Li K, Zhong C, Qiu Z, Li K, Lin Z, Yang Z, Zuo D, Qiu J, He W, Wang C, Liao Y, Wang G, Yuan Y, Li B.
Shi Y, et al. Among authors: li k, li b.
Nat Commun. 2023 Apr 6;14(1):1932. doi: 10.1038/s41467-023-37542-5.
Nat Commun. 2023.
PMID: 37024475
Free PMC article.